Navigation Links
Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
Date:6/18/2008

MEXICO CITY, June 18 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma" or "the Company") today announced the pricing of its initial public offering. The offering consisted of 130,869,566 series B shares; 73.5% was placed with international investors and 26.5% was placed with Mexican investors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080618/MXW007LOGO )

Excluding the overallotment option, 23.1% of the total offering size is being sold by Invex Trust No. 414 (existing shareholders) and ZN Mexico II, L.P. (one of the Nexxus family of Funds) on a pro rata basis. The shares are now listed on the Mexican Stock Exchange (ticker symbol "LAB"), and were distributed to institutional investors in the U.S. under Rule 144A and to investors outside the U.S. and elsewhere under Reg S.

The shares were offered at a price of Ps. 16 per Series B share, equivalent to US$1.54. At such price, the aggregate value of the offering is 2.4 billion pesos (2,408 millones de pesos) or approximately 233.6 million dollars, including overallotment options.

The Company's Chairman and Chief Executive Officer, Rodrigo Herrera, stated, "We are proud to be the first over-the-counter pharmaceutical and personal care products company that is traded on the Mexican Stock Exchange. This offering was successfully completed in very challenging market conditions and we thank everyone involved for their support.

"We plan to use these funds to support our rapid growth and we look forward to many years of continued expansion in the Mexican market."

Both the international offering and the local offering were well oversubscribed. Approximately 70% of the international offering was sold in the U.S. and 30% in Europe and the rest of the world. As a result of the Company's roadshow, the international book of demand was of exceptionally high quality and consisted of a combination of dedicated healthcare specialists and dedicated Latin American investors.

UBS Investment Bank was sole global coordinator of the international offering and joint bookrunner with Merrill Lynch. The lead underwriters of the Mexican offering were IXE Casa de Bolsa, S.A. de C.V., and Casa de Bolsa Santander, S.A. de C.V.

About Genomma

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico. Genomma trades on the Mexican Stock Exchange under the ticker symbol LAB.

Contact:

Maria Barona

Tel: (212) 406-3691

mbarona@i-advize.com


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Impact of Rising Gas, Food Prices Felt Globally
2. Economy, Health Care, and Gas Prices Top Issues for Women Business Owners
3. World fertilizer prices continue to soar, scientists stress need for fertilizer efficiency
4. California Green and Organic Purchasing Strong Despite Rising Prices Says Mambo Sprouts Survey
5. Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills
6. Eat Well, Save Money: BJs Offers Everyday Low Prices on Top Quality Organic Groceries, Natural Foods Versus Supermarket Prices
7. PCMA: Skyrocketing Biotech Prices Challenge Employers, Consumers
8. MIT: Rx for high drug prices
9. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
10. New Report Finds Mandatory Price Disclosure for Med Tech Would Likely Increase Prices
11. New Study Finds Slow Rate of Growth in Overall Medical Technology Prices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon ... this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss ...
(Date:3/28/2017)... ... March 28, 2017 , ... Silicon Valley Hair Institute, the San Francisco Bay ... post about women’s hair loss. Although hair transplant procedures can be seen as more ... or genetics can be two reasons a woman may see her hair thinning. , ...
(Date:3/28/2017)... ... 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. ... that his parents and teachers had asked of him that he had neglected to do, ... defy the Almighty Creator. There were some who would have felt themselves to be special ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. ... smile makeovers without requiring a referral. Trimble Dental offers a variety of ... dentistry and dental implants. Whether patients have discolored, crooked or missing teeth in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... to the OSEHRA popHealth Community in 2014. It is the culmination ... the Developer Open Source Project Group. OSEHRA Organizational Member Zato Health co-funded the ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 ... attention to these four stocks: The Medicines Co. ... Pharmaceuticals Inc. (NASDAQ: PCRX), and Supernus Pharmaceuticals Inc. ... in the Generic Drugs space which is governed ... The key growth drivers for the industry are wholesalers, ...
(Date:3/28/2017)... 2017 RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... Patent Office (JPO) for the composition of matter ... for the treatment or prevention of fibrotic disorders, ... proliferative retinopathy (Japanese Patent #: 6060071).  This patent ...
(Date:3/27/2017)... SINGAPORE , March 27, 2017 ... a digital health and data analytics company, signed ... collaborations for improving healthcare delivery in the region. ... Institute for Global Health Research and Technology (BIGHEART) ... relationship on several topics related to healthcare IT ...
Breaking Medicine Technology: